Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | SVP and CHRO | March 12, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date March 12, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,224 |
Reported balance
After 2026-03-12 transaction · row 1
1 source rowRow 1 · 2026-03-12 · Sale · Disposed 2,650 · Balance 10,224 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 6, 2023 21:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 56 | $122.14 | $6,839.84 |
DisclosureSEC source: 0001062993-23-006058 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 187 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006058 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSU's) reflects the adjustment that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company's") spinoff of ZimVie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 2 shares acquired pursuant to dividend reinvestment between April 27, 2022 and January 27, 2023. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 21:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 65 | $123.08 | $8,000.20 |
DisclosureSEC source: 0001062993-22-007442 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units. F2 · balance_after: Holdings reflect the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. On March 4, 2022, the reporting person reported the acquisition of 181 shares upon the vesting of restricted stock units on March 2, 2022, which did not yet reflect certain adjustments made to outstanding equity awards effective March 1, 2022 in connection with the spinoff to preserve the intrinsic value of such awards, because the exchange ratio to be used for such adjustments had not yet been determined. Subsequently, the exchange ratio calculation was completed, and the 181 shares were adjusted to 187 shares, which is now reflected in the reporting person's total holdings. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006834 · form4.xml · derivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362 Underlying: Common Stock · 181 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The RSUs vest in equal portions on each of March 2, 2022, March 2, 2023 and March 2, 2024. F3 · derivative.expiration_date: The RSUs vest in equal portions on each of March 2, 2022, March 2, 2023 and March 2, 2024. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006834 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1 share acquired pursuant to dividend reinvestment between April 28, 2021 and January 27, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 748 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006636 · form4.xml · derivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748 Underlying: Common Stock · 748 shares Expires 2024-04-01 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, as indicated in the table above. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, as indicated in the table above. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006636 · form4.xml · derivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 1,254 shares Expires 2024-02-25 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, as indicated in the table above. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, as indicated in the table above. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 22:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 16,682 | $0.00 Strike: $120.82 | $0.00 |
DisclosureSEC source: 0001062993-22-005371 · form4.xml · derivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,682 Underlying: Common Stock · 16,682 shares Expires 2032-02-18 F1 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on February 18, 2023. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 3,988 | $0.00 Strike: $159.47 | $0.00 |
DisclosureSEC source: 0001062993-21-003427 · form4.xml · derivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,988 Underlying: Common Stock · 3,988 shares Expires 2031-04-01 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on April 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.